HRT Financial’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-971
| Closed | -$6K | – | 3128 |
|
|
2023
Q4 | $6K | Buy |
+971
| New | +$6K | ﹤0.01% | 1958 |
|
|
2022
Q4 | – | Sell |
-755
| Closed | -$170K | – | 3168 |
|
|
2022
Q3 | $170K | Buy |
+755
| New | +$170K | ﹤0.01% | 2089 |
|
|
2021
Q4 | – | Sell |
-645
| Closed | -$129K | – | 3976 |
|
|
2021
Q3 | $129K | Buy |
+645
| New | +$129K | ﹤0.01% | 2563 |
|
|
2021
Q2 | – | Sell |
-622
| Closed | -$165K | – | 3487 |
|
|
2021
Q1 | $165K | Buy |
+622
| New | +$165K | ﹤0.01% | 2133 |
|